These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J. Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541 [Abstract] [Full Text] [Related]
3. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Bojsen-Møller KN. Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541 [Abstract] [Full Text] [Related]
4. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR. Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383 [Abstract] [Full Text] [Related]
5. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G. Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352 [Abstract] [Full Text] [Related]
6. Gastric bypass significantly improves quality of life in morbidly obese patients with type 2 diabetes. Omotosho P, Mor A, Shantavasinkul PC, Corsino L, Torquati A. Surg Endosc; 2016 Jul; 30(7):2857-64. PubMed ID: 26823053 [Abstract] [Full Text] [Related]
9. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Malin SK, Samat A, Wolski K, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR. Int J Obes (Lond); 2014 Mar; 38(3):364-70. PubMed ID: 24166065 [Abstract] [Full Text] [Related]
10. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Diabetes; 2003 May; 52(5):1098-103. PubMed ID: 12716738 [Abstract] [Full Text] [Related]
12. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Morínigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J. Obes Surg; 2006 Dec; 16(12):1594-601. PubMed ID: 17217635 [Abstract] [Full Text] [Related]
13. Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis. Liaskos C, Koliaki C, Alexiadou K, Argyrakopoulou G, Tentolouris N, Diamantis T, Alexandrou A, Katsilambros N, Kokkinos A. Obes Surg; 2018 Dec; 28(12):3997-4005. PubMed ID: 30112599 [Abstract] [Full Text] [Related]
14. Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study. Nosso G, Griffo E, Cotugno M, Saldalamacchia G, Lupoli R, Pacini G, Riccardi G, Angrisani L, Capaldo B. Horm Metab Res; 2016 May; 48(5):312-7. PubMed ID: 26788926 [Abstract] [Full Text] [Related]